Skip to main content
Jasper Therapeutics, Inc. logo

Jasper Therapeutics, Inc. — Investor Relations & Filings

Ticker · JSPR ISIN · US4718712023 US Professional, scientific and technical activities
Open in API
Filings indexed 422 across all filing types
Latest filing 2021-09-08 Regulatory Filings
Country US United States of America
Listing US JSPR

About Jasper Therapeutics, Inc.

https://jaspertx.com/

Jasper Therapeutics, Inc. is a clinical-stage biotechnology company that develops therapies targeting mast and hematopoietic stem cells. The company's lead product candidate is briquilimab, a monoclonal antibody that targets c-Kit (CD117). This therapeutic is designed to deplete mast cells for the treatment of chronic immunological and inflammatory diseases. Jasper Therapeutics is conducting clinical studies to evaluate briquilimab in patients with chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU), and allergic asthma. The company's mission is to provide safer and more effective therapies for patients with chronic mast cell-driven diseases.

Recent filings

Filing Released Lang Actions
425 Filing
Regulatory Filings
2021-09-08 English
Regulatory Filings 2021
Regulatory Filings
2021-08-27 English
Regulatory Filings 2021
Regulatory Filings
2021-08-27 English
PROSPECTUS
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a proxy statement/prospectus filed pursuant to Rule 424(b)(3) related to a special meeting of stockholders of Amplitude Healthcare Acquisition Corporation (AMHC). It details the proposed Business Combination (merger) with Jasper Therapeutics, including voting proposals for stockholders, amendments to the certificate of incorporation and bylaws, and other related corporate governance matters. The document is not a financial report, earnings release, or audit report, but rather a solicitation of shareholder votes and information about the merger transaction. This fits the definition of a Proxy Solicitation & Information Statement (PSI). The document length is substantial (15,000 characters), and it contains detailed information for shareholders to make informed voting decisions, consistent with a proxy statement. Therefore, the correct classification is PSI with high confidence.
2021-08-26 English
REGISTRATION STATEMENT
Proxy Solicitation & Information Statement Classification · 95% confidence The document is an Amendment No. 4 to Form S-4 filed with the SEC, which is a registration statement under the Securities Act of 1933. It relates to a business combination (merger) between Amplitude Healthcare Acquisition Corporation and Jasper Therapeutics, Inc. The text includes a proxy statement/prospectus for a special meeting of stockholders to vote on the business combination and related matters. The document is detailed and includes information about the transaction, stock issuance, and shareholder voting. This type of filing is primarily related to merger and acquisition activity and proxy solicitation for shareholder approval of the transaction. Given the detailed proxy statement and the focus on the business combination, the most appropriate classification is Proxy Solicitation & Information Statement (PSI). It is not merely an announcement or a brief summary, but a comprehensive proxy statement/prospectus for a special meeting related to a merger transaction.
2021-08-25 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC requesting acceleration of the effective date for a Registration Statement on Form S-4. It is a formal correspondence related to a securities registration process, specifically concerning a merger or acquisition transaction. The document does not contain financial statements, audit information, or detailed report content. It is a regulatory filing related to the registration and effectiveness of a securities offering, which fits best under the category of Regulatory Filings (RNS). The document length is short and it is a formal request letter, not a report or announcement of voting results or capital changes.
2021-08-25 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.